Time to really share real-world data? [version 1; referees: 2 approved, 1 approved with reservations]
Data other than that from clinical trials are important for healthcare decision making. However, unlike the vocal calls seen for more open access to trial data, there are limited efforts being made to ensure that agencies that collect real-world data (RWD) share this, despite its importance. There a...
Main Authors: | Sophie Graham, Laura McDonald, Radek Wasiak, Michael Lees, Sreeram Ramagopalan |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-07-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-1054/v1 |
Similar Items
-
A review of data sharing statements in observational studies published in the BMJ: A cross-sectional study [version 2; referees: 2 approved]
by: Laura McDonald, et al.
Published: (2017-11-01) -
Unintended consequences of machine learning in medicine? [version 1; referees: 2 approved]
by: Laura McDonald, et al.
Published: (2017-09-01) -
Sleep and BMI: Do (Fitbit) bands aid? [version 2; referees: 2 approved]
by: Laura McDonald, et al.
Published: (2018-09-01) -
FAIRness in scientific publishing [version 1; referees: 1 approved, 2 approved with reservations]
by: Philippa C. Matthews
Published: (2016-12-01) -
Automated Wormscan [version 2; referees: 2 approved, 1 approved with reservations]
by: Timothy Puckering, et al.
Published: (2017-09-01)